scholarly journals National Breast Cancer Mortality and Incidence Rates According to the Human Development Index: An Ecological Study

2016 ◽  
Vol 05 (01) ◽  
pp. 30-36 ◽  
Author(s):  
Salman Khazaei ◽  
Shahab Rezaeian ◽  
Zaher Khazaei ◽  
Leila Molaeipoor ◽  
Shahrzad Nematollahi ◽  
...  
2021 ◽  
Vol 10 ◽  
Author(s):  
Juliana Dalcin Donini E. Silva ◽  
Rosana Rosseto de Oliveira ◽  
Mariana Teixeira da Silva ◽  
Maria Dalva de Barros Carvalho ◽  
Raissa Bocchi Pedroso ◽  
...  

ObjectiveMalignant breast cancer is the leading cause of death by cancer in young women. The study aimed to determine if breast cancer mortality among young women has increased between the period from 1996 to 2017 in Brazil.MethodsA time-series analysis of breast cancer mortality rate in young women (20–39 years old) was carried out. Mortality data, from 1996 to 2017, were collected from the Mortality Information System of the Health Ministry, and demographic data, from the Brazilian Institute of Geography and Statistics. Trends in mortality were performed by Joinpoint Regression, the spatial distribution of the mortality rate was done with the QGIZ Software version 2.18, and Spearman’s correlation coefficient was used to correlate the mortality rates with the Human Development Index.ResultsThere was an increase in breast cancer mortality rates in young women in the majority of Brazilian states, with an upward trend in all regions. The correlation with the Municipal Human Development Index, income, and education had a significant impact on the mortality rate for women from 30–39 years old in both time frames evaluated and for women from 20–29 years old, only from 1996 to 2000.ConclusionThe data obtained in the study, showed that even though the breast cancer mortality rate of young women is lower than women over 40 years old, it has been increasing in all regions of Brazil, mostly for women from 30–39 years old, suggesting that this group should be included in screening programs.


2021 ◽  
Author(s):  
Diego Rodrigues Mendonça e Silva ◽  
Max Moura Oliveira ◽  
Gisele Aparecida Fernandes ◽  
Maria Paula Curado

Abstract Pancreatic cancer mortality is greatest in countries with a high and very high Human Development Index (HDI). The aim was to evaluate the pancreatic cancer mortality rates and trends related to HDI in Brazil by state. An ecological study was conducted on pancreatic cancer mortality in Brazilian states between 1979 and 2019. Age-standardized mortality rates (ASMR) and Annual Average Percent Change (AAPC) were calculated. Pearson´s correlation test was applied to compare rates over the 3 decades from 1986-2015 to verify correlation between change in HDI from 1991 to 2010. A total of 209,425 deaths from pancreatic cancer were reported in Brazil from 1979 to 2019. In men, ASMRs ranged from 2.9/100,000 in 1979 to 6.1/100,000 in 2019, with AAPC of 1.5% per year, and in women, ASMR ranged from 2.1/100,000 in 1979 to 4.7/100,000 in 2019, with AAPC of 1.9% per year. Mortality rates and trends increase with higher % of HDI improvement with a correlation between ASMRs and HDI above r>0.80. The mortality trends in pancreatic cancer were uneven increase in Brazil, there was an upward trend in mortality in both genders, but higher among women. Pancreatic cancer mortality trends were higher in those states where there was greatest increase in HDI, regions as North and Northeast. However, mortality rates remain higher in South, Southeast and Central-West of Brazil.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Marcela Sampaio Lima ◽  
Hianga Fayssa Fernandes Siqueira ◽  
Alex Rodrigues Moura ◽  
Evânia Curvelo Hora ◽  
Hugo Leite de Farias Brito ◽  
...  

AbstractEmerging economy countries in epidemiological transition have been especially challenged in the fight against cancer. This was an ecological study that aimed to describe the temporal trend of cancer mortality in a Brazilian northeastern state with a medium Human Development Index using official Brazilian mortality data from 1980 to 2018. We calculated the mortality crude rate (CR) and age-standardized rate (ASR) based on official population counts and estimates. The Joinpoint Regression Program, National Cancer Institute, USA, was used to calculate time trends of cancer mortality. There were 34,214 deaths from cancer, excluding nonmelanoma skin cancer, in Sergipe. The overall cancer mortality ASR was 70.1 and 57.9 per 100,000 men and women, respectively. For the last five years, the leading causes of cancer deaths were prostate (21.3), trachea, bronchus and lung (11.7), stomach (6.5), oral cavity (5.4) and liver and intrahepatic bile ducts (5.1) in males and breast (13.8), trachea, bronchus and lung (6.6), cervix (6.4), colon/rectum (5.8) and central nervous system (3.6) in females. In addition, there was a significant reduction in deaths from ill-defined causes in the series. Our results show that although there has been an increase in cancer mortality rates associated with Western lifestyles, such as prostate, breast and colon/rectum, high rates of cancer related to poverty and infections, such as stomach and cervix, still persist in Sergipe.


2018 ◽  
Vol 7 (1) ◽  
pp. 20-23 ◽  
Author(s):  
Vicente Livacic ◽  
◽  
José Tomás Grez ◽  
Jorge Candia ◽  
Alejandra Fernández ◽  
...  

2009 ◽  
Vol 27 (35) ◽  
pp. 5919-5923 ◽  
Author(s):  
Philippe Autier ◽  
Clarisse Héry ◽  
Jari Haukka ◽  
Mathieu Boniol ◽  
Graham Byrnes

Purpose We assessed changes in advanced cancer incidence and cancer mortality in eight randomized trials of breast cancer screening. Patients and Methods Depending on published data, advanced cancer was defined as cancer ≥ 20 mm in size (four trials), stage II+ (four trials), and ≥ one positive lymph node (one trial). For each trial, we obtained the estimated relative risk (RR) and 95% CI between the intervention and control groups, for both breast cancer mortality and diagnosis of advanced breast cancer. Using a meta-regression approach, log(RR-mortality) was regressed on log(RR-advanced cancer), weighting each trial by the reciprocal of the square of the standard error of log(RR) for mortality. Results RR for advanced breast cancer ranged from 0.69 (95% CI, 0.61 to 0.78) in the Swedish Two-County Trial to 0.97 (95% CI, 0.97 to 1.25) in the Canadian National Breast Screening Study-1 (NBSS-1) trial. Log(RR)s for advanced cancer were highly predictive of log(RR)s for mortality (R2 = 0.95; P < .0001), and the linear regression curve had a slope of 1.00 (95% CI, 0.76 to 1.25) after fixing the intercept to zero. The slope changed only slightly after excluding the Two-County Trial and the Canadian NBSS-1 and NBSS-2 trials. Conclusion In trials on breast cancer screening, for each unit decrease in incidence of advanced breast cancer, there was an equal decrease in breast cancer mortality. Monitoring of incidence of advanced breast cancer may provide information on the current impact of screening on breast cancer mortality in the general population.


Sign in / Sign up

Export Citation Format

Share Document